Evidence map›Paper›PMID 30808328›Full record

ArticleBMC medical genetics2019

HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia.

Flora Cimmino, Marianna Avitabile, Vito Alessandro Lasorsa, Annalaura Montella, Lucia Pezone, Sueva Cantalupo, Feliciano Visconte, Maria Valeria Corrias, Achille Iolascon, Mario Capasso

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Review
  3. Effects of Gelatin Hydrolysate from Bigeye Snapper (International journal of molecular sciences · 2026
    Article
  4. Review
  5. Regulatory T cells in hypoxic environments.Frontiers in immunology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Flora CimminoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. cimminof@ceinge.unina.it.ORCID 0000-0003-1538-9285
Marianna AvitabileDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Vito Alessandro LasorsaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Annalaura MontellaCEINGE Biotecnologie Avanzate, Naples, Italy.
Lucia PezoneDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Sueva CantalupoCEINGE Biotecnologie Avanzate, Naples, Italy.
Feliciano VisconteCEINGE Biotecnologie Avanzate, Naples, Italy.
Maria Valeria CorriasExperimental therapy in Oncology, Istituto Giannina Gaslini, Genoa, Italy.
Achille IolasconDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Mario CapassoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Ceinge Biotecnologie Avanzate (Italy) · ITIstituto Giannina Gaslini · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIF1A (Hypoxia-Inducible-Factor 1A) expression in solid tumors is relevant to establish resistance to therapeutic approaches. The use of compounds direct against hypoxia signaling and HIF1A does not show clinical efficiency because of changeable oxygen concentrations in solid tumor areas. The identification of HIF1A targets expressed in both normoxia and hypoxia and of HIF1A/hypoxia signatures might meliorate the prognostic stratification and therapeutic successes in patients with high-risk solid tumors.

methodsIn this study, we conducted a combined analysis of RNA expression and DNA methylation of neuroblastoma cells silenced or unsilenced for HIF1A expression, grown in normoxia and hypoxia conditions.

resultsThe analysis of pathways highlights HIF-1 (heterodimeric transcription factor 1) activity in normoxia in metabolic process and HIF-1 activity in hypoxia in neuronal differentiation process. HIF1A driven transcriptional response in hypoxia depends on epigenetic control at DNA methylation status of gene regulatory regions. Furthermore, low oxygen levels generate HIF1A-dependent or HIF1A-independent signatures, able to stratify patients according to risk categories.

conclusionsThese findings may help to understand the molecular mechanisms by which low oxygen levels reshape gene signatures and provide new direction for hypoxia targeting in solid tumor.

Indexed as

DNA MethylationGene Regulatory NetworksCell DifferentiationCell HypoxiaCell Line, TumorCpG IslandsEpigenesis, GeneticGene Expression ProfilingGene SilencingHumansHypoxia-Inducible Factor 1, alpha SubunitNeuroblastomaNeuronsPrognosisSequence Analysis, RNAHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitDNA methylationHypoxia inducible factor HIF1ANeuroblastomaRNA sequencing

Identifiers

PMID30808328
PMCPMC6390360
OpenAlexW2924421333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.